$2.46T
Total marketcap
$62.97B
Total volume
BTC 50.76%     ETH 15.11%
Dominance

Proto Script Pharmaceutical PSCR Stock

0.0002 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
90.42K USD
LOW - HIGH [24H]
0.0002 - 0.0002 USD
VOLUME [24H]
5.9K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Proto Script Pharmaceutical Price Chart

Proto Script Pharmaceutical PSCR Financial and Trading Overview

Proto Script Pharmaceutical stock price 0.0002 USD
Previous Close 0.0002 USD
Open 0.0002 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0002 - 0.0002 USD
52 Week Range 0.0002 - 0.0011 USD
Volume 7.85K USD
Avg. Volume 1.79K USD
Market Cap 90.42K USD
Beta (5Y Monthly) -1.404577
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

PSCR Valuation Measures

Enterprise Value 384.07K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.14945526
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.635
Enterprise Value/EBITDA -0.399

Trading Information

Proto Script Pharmaceutical Stock Price History

Beta (5Y Monthly) -1.404577
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.0011 USD
52 Week Low 0.0002 USD
50-Day Moving Average 0.0002 USD
200-Day Moving Average 0.00049 USD

PSCR Share Statistics

Avg. Volume (3 month) 1.79K USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 49.14M
Float 44.82M
Short Ratio N/A
% Held by Insiders 10.17%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 10:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2016
Most Recent Quarter (mrq) September 30, 2017
Next Fiscal Year End December 31, 2017

Profitability

Profit Margin 0%
Operating Margin (ttm) -160.49%
Gross Margin 58.15%
EBITDA Margin -159.10%

Management Effectiveness

Return on Assets (ttm) -240.96%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 604.98K USD
Revenue Per Share (ttm) 0.004 USD
Quarterly Revenue Growth (yoy) 17.80%
Gross Profit (ttm) 564.47K USD
EBITDA -962569 USD
Net Income Avi to Common (ttm) -8386297 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) 372.75K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.111
Book Value Per Share (mrq) -0.029

Cash Flow Statement

Operating Cash Flow (ttm) -303097 USD
Levered Free Cash Flow (ttm) 406.84K USD

Profile of Proto Script Pharmaceutical

Country United States
State CA
City Rancho Cucamonga
Address 9830 6th Street
ZIP 91730
Phone 855-476-7679
Website https://www.psphomecare.com
Industry Specialty Business Services
Sector(s) Industrials
Full Time Employees N/A

Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.

Q&A For Proto Script Pharmaceutical Stock

What is a current PSCR stock price?

Proto Script Pharmaceutical PSCR stock price today per share is 0.0002 USD.

How to purchase Proto Script Pharmaceutical stock?

You can buy PSCR shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Proto Script Pharmaceutical?

The stock symbol or ticker of Proto Script Pharmaceutical is PSCR.

Which industry does the Proto Script Pharmaceutical company belong to?

The Proto Script Pharmaceutical industry is Specialty Business Services.

How many shares does Proto Script Pharmaceutical have in circulation?

The max supply of Proto Script Pharmaceutical shares is 452.09M.

What is Proto Script Pharmaceutical Price to Earnings Ratio (PE Ratio)?

Proto Script Pharmaceutical PE Ratio is now.

What was Proto Script Pharmaceutical earnings per share over the trailing 12 months (TTM)?

Proto Script Pharmaceutical EPS is 0 USD over the trailing 12 months.

Which sector does the Proto Script Pharmaceutical company belong to?

The Proto Script Pharmaceutical sector is Industrials.